Skip to main content

Investigating the safety and efficacy, quality of life, cost-efficiency and immune potential of high precision lung radiotherapy

Project Member(s): Haas, M.

Funding or Partner Organisation: Cancer Australia

Start year: 2015

Summary: This project investigates the safety and efficacy, quality of life, cost-efficiency and immune potential of high precision lung radiotherapy

Publications:

Siva, S, Kron, T, Bressel, M, Haas, MR, Mai, T, Vinod, S, Sasso, G, Wong, W, Le, H, Eade, T, Hardcastle, N, Chesson, B, Pham, D, Høyer, M, Montgomery, R & Ball, D 2016, 'A Randomised Phase II Trial of Stereotactic Ablative Fractionated Radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the Lung (TROG 13.01 SAFRON II)', BMC Cancer, vol. 16.
View/Download from: Publisher's site

FOR Codes: Health Economics, Radiation Therapy, Health Policy Economic Outcomes, Health Policy Evaluation